
Uromax0.4 mg
Unimed Unihealth MFG. Ltd.
Tamsulosin Hydrochloride is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men, such as difficulty urinating, weak urinary stream and more.
Tamsulosin Hydrochloride is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men, such as difficulty urinating, weak urinary stream, urinary frequency, urgency, and incomplete bladder emptying.
Tamsulosin Hydrochloride is not indicated for the treatment of hypertension and is not indicated for use in women or children, as BPH is a condition specific to the male prostate gland.
| Step | Dose | Notes |
|---|---|---|
| Initial | 0.4 mg once daily | Take approximately 30 minutes after the same meal every day |
| If inadequate response | May increase to 0.8 mg once daily | After 2-4 weeks of the initial dose |
No dosage adjustment of Tamsulosin Hydrochloride is required in mild to moderate renal impairment. Use in severe renal impairment or end-stage renal disease has not been well studied; caution is advised.
No dosage adjustment is required in mild to moderate hepatic impairment. Use in severe hepatic impairment has not been studied and is not recommended.
Tamsulosin Hydrochloride is not indicated for use in women or in children.
The most commonly reported side effects of Tamsulosin Hydrochloride (occurring in ≥2% of patients and more often than with placebo) include:
Less common but important effects include postural (orthostatic) hypotension and syncope, particularly with the first few doses (see Precautions and Warnings), and rare reports of priapism (a prolonged, painful erection requiring emergency treatment) and intraoperative floppy iris syndrome during cataract surgery.
Tamsulosin Hydrochloride is contraindicated in patients with a known history of hypersensitivity to tamsulosin hydrochloride or to any component of the formulation. Hypersensitivity reactions have included skin rash, urticaria, pruritus, angioedema, and, rarely, severe respiratory or skin reactions (e.g. Stevens-Johnson syndrome has been reported rarely).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.